It seems we can’t find what you’re looking for. Perhaps searching can help.
1933 - 2033
Odette Cancer Centre – A Multi-Center, Open-Label, Single-Arm Phase II Trial of Bendamustine, Rituximab and the Second Generation BTK Inhibitor Acalabrutinib in Previously Untreated Waldenstrom’s Macroglobulinemia (BRAWM)